The Rho-associated protein kinase-mediated signaling pathway is known to be involved in the vascular effects of angiotensin II [65], and renin-angiotensin system blockade is beneficial to the cardiovascular system and a known treatment for diabetic cardiomyopathy [66]. The gene discussed is REN; the disease is diabetic cardiomyopathy.